ѻý

<ѻý class="page-title">Nephrology

General Nephrology

<ѻý class="page-description">

More in General Nephrology

FDA Panel Rejects SGLT1/2 Inhibitor for Type 1 Diabetes

Data too uncertain to support sotagliflozin in subset with chronic kidney disease, advisors say

Nov 01, 2024
FDA ADCOMM sotagliflozin over a computer rendering of chronic kidney disease.
Ex-Gov. May Face Charges Over COVID; Autism Dx Up 175%; Can Fasting Help Kidneys?

Health news and commentary gathered by ѻý staff

Oct 31, 2024
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.
FDA Staff Not Quite Sold on Sotagliflozin for T1D Patients With CKD

SGLT1/SGLT2 inhibitor has another shot in T1D, but now in more narrow patient population

Oct 30, 2024
 FDA ADCOMM sotagliflozin over a computer rendering of chronic kidney disease.
Colorado Teen Fights Kidney Failure After Eating McDonald's Quarter Pounders

Deadly E. coli outbreak has been tentatively traced to contaminated onions

Oct 30, 2024
A selfie of Brittany Randall and her daughter Kamberlyn Bowler in Grand Junction Colorado in the summer of 2024.
Wegovy Cut Albuminuria by Half in Non-Diabetic CKD

However, 24 weeks of the GLP-1 had no impact on eGFR

Oct 29, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
Early AKI Care Recommendations Did Not Improve Patient Outcomes

Personalized recs were made by team of physicians and pharmacists within an hour of diagnosis

Oct 29, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
SGLT2 Inhibitor Carry-Over Benefits Last How Long?

Trial follow-up defines the need for long-term treatment in protecting the kidneys and heart

Oct 29, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
Kidney Disease Genetic Risk Common in West Africans

Observational study points to genetic risk allele dose-response

Oct 29, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
No Kidney Benefit With Finerenone in Heart Failure Patients

Anti-mineralocorticoid agent reduced albuminuria, but not eGFR-based kidney outcome

Oct 28, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
Complement Inhibitor Shows Promise for Rare Kidney Disorder

Ravulizumab reduced proteinuria, stabilized eGFR in IgA nephropathy

Oct 28, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
Interim ALIGN Data: Atrasentan Cuts Proteinuria in IgA Nephropathy

Surrogate endpoint of urinary protein-to-creatinine ratio "widely considered to be predictive"

Oct 27, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
Alternative Pathway Inhibition Makes Good in IgA Nephropathy

Treatment with iptacopan reduces proteinuria in interim APPLAUSE-IgAN analysis

Oct 26, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
Pediatric Febrile UTI May Hurt Kidney Function

Study also raises question of antibiotic prophylaxis in kids with common congenital anomaly

Oct 26, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
Kidney Transplant Trouble Spelled Out for Newer Rejection Episode Categories

Study details an intermediate prognosis with newer microvascular inflammation phenotypes

Oct 25, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
More in General Nephrology